FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yves Beguin

Research Profile

Chemicals & Drugs

Procedures

Physiology

Erythropoiesis

Disorders

Anatomy

Hematopoietic Stem Cells

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
France Bruck; Emilie Castermans; Laurence de Leval; Sophie Dubois; Muriel Hannon; Stéphanie Humblet-Baron; Chantal Lechanteur; Souad Rahmouni; Yves Beguin; Ludovic Belle; Alexandra Briquet; Frédéric Baron
Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
Aurélie Jaspers; Gerald Le Gac; Yves Beguin; Jo Caers; Claude Ferec; Georges Fillet
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
Eléonore Otjacques; Natacha Rocks; Karin Vanderkerken; Didier Cataldo; Agnès Noel; Yves Beguin; Marilène Binsfeld; Silvia Blacher; Jo Caers
Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yves Beguin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: France Bruck; Emilie Castermans; Laurence de Leval; Sophie Dubois; Muriel Hannon; Stéphanie Humblet-Baron; Chantal Lechanteur; Souad Rahmouni; Yves Beguin; Ludovic Belle; Alexandra Briquet; Frédéric Baron
Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
Cytotherapy 2013;15(3):267-79.
2013: Aurélie Jaspers; Gerald Le Gac; Yves Beguin; Jo Caers; Claude Ferec; Georges Fillet
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
British journal of haematology 2013;160(4):564-5.
2013: Eléonore Otjacques; Natacha Rocks; Karin Vanderkerken; Didier Cataldo; Agnès Noel; Yves Beguin; Marilène Binsfeld; Silvia Blacher; Jo Caers
Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors.
PloS one 2013;8(5):e62818.
2013: S Servais; E Willems; Yves Beguin; Frédéric Baron
[Allogeneic hematopoietic stem cell transplantation: what is the upper age limit?].
Revue médicale de Liège 2013;68(1):38-43.
2013: Muriel De Bock; Marianne Fillet; André Gothot; Muriel Hannon; Marie-Paule Merville; Laurence Seidel; Yves Beguin; Frédéric Baron
Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioning.
PloS one 2013;8(2):e55876.
2013: Jean-Philippe Hauzeur; Yves Beguin; Claire Bernard; Dominique Egrise; Philippe Gillet; William Kurth; Chantal Lechanteur; Michel Malaise; Henry Van Cauwenberge; Roland Hustinx
(111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures.
International orthopaedics 2013;37(1):131-6.
2012: N Frusch; Renaud Louis; S Servais; Yves Beguin; Jean-Louis Corhay; B De Prijck; Bernard Duysinx
Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis.
Acta clinica Belgica 2012;67(5):370-1.
2012: C Bonnet; B De Prijck; Marie-France Fassotte; M Lejeune; E Van Den Neste; Yves Beguin
[Diffuse large B cell lymphoma: management in 2012].
Revue médicale suisse 2012;8(351):1582-4, 1586-90.
2012: Mustapha Zeddou; Olivier Malaise; Biserka Relic; Yves Beguin; Edith Charlier; Dominique de Seny; Aline Desoroux; Michel G Malaise
Differential signalling through ALK-1 and ALK-5 regulates leptin expression in mesenchymal stem cells.
Stem cells and development 2012;21(11):1948-55.
2012: G Vertenoeil; S Servais; Yves Beguin
[How to explore a fever of unknown origin in adult patients?].
Revue médicale de Liège 2012;67(7-8):391-7.
2012: Ludovic Belle; Frédéric Baron; Yves Beguin; France Bruck; Jacques Foguenne; André Gothot; Alexandra Briquet
Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells.
PloS one 2012;7(12):e52564.
2012: Véronique Roelants; stephan walrand; Yves Beguin; Marie Delgaudine; François Jamar; Renaud Lhommel; Jean-Louis Vanoverschelde
Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database.
EJNMMI research 2012;2(1):64.
2011: Sophie Servais; Frédéric Baron; Yves Beguin
Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2011;44(2):205-10.
2011: Emilie Castermans; Muriel Hannon; Jacques Dutrieux; Stéphanie Humblet-Baron; Laurence Seidel; remi cheynier; Evelyne Willems; André Gothot; Jean-François Vanbellinghen; Vincent Geenen; Brenda M Sandmaier; Rainer Storb; Yves Beguin; Frédéric Baron
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Haematologica 2011;96(2):298-306.
2011: Marie Delgaudine; Bernard Lambermont; Patrizio Lancellotti; Véronique Roelants; Stéphan Walrand; Jean-Louis Vanoverschelde; Luc Pierard; André Gothot; Yves Beguin
Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice.
Cytotherapy 2011;13(2):237-47.
2010: Sophie Servais; Jo Caers; Odile Warling; Nicolas Frusch; Frédéric Baron; Bernard De Prijck; Yves Beguin
Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
British journal of haematology 2010;150(3):379-81.
2010: Mustapha Zeddou; Alexandra Briquet; Biserka Relic; Claire Josse; Michel G Malaise; André Gothot; Chantal Lechanteur; Yves Beguin
The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood.
Cell biology international 2010;34(7):693-701.
2010: Frédéric Baron; Chantal Lechanteur; Evelyne Willems; France Bruck; Etienne Baudoux; Laurence Seidel; Jean-François Vanbellinghen; Kaoutar Hafraoui; Marie Lejeune; André Gothot; Georges Fillet; Yves Beguin
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(6):838-47.
2010: R Roufosse; Yves Beguin
[Therapeutic observance in haematology: the particular case of chronic myeloid leukemia].
Revue médicale de Liège 2010;65(5-6):409-12.
2010: A Jaspers; Frédéric Baron; C Bonnet; B De Prijck; Marie-France Fassotte; Yves Beguin
[Mantle cell lymphoma].
Revue médicale de Liège 2010;65(4):171-6.
2010: Evelyne Willems; Frédéric Baron; L Seidel; Pascale Frère; Georges Fillet; Yves Beguin
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
Bone marrow transplantation 2010;45(4):689-93.
2010: Alexandra Briquet; Sophie Dubois; Sandrine Bekaert; Marie Dolhet; Yves Beguin; André Gothot
Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages.
Haematologica 2010;95(1):47-56.
2009: Biserka Relic; Mustapha Zeddou; Aline Desoroux; Yves Beguin; Dominique de Seny; Michel Malaise
Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts.
Laboratory investigation; a journal of technical methods and pathology 2009;89(7):811-22.
2009: C Bonnet; Yves Beguin; B De Prijck; N Witvrouw; Roland Hustinx; Georges Fillet
[Monoclonal antibodies in hematology in 2009].
Revue médicale de Liège 2009;64(5-6):268-73.
2009: Jacques Foguenne; Ivano Di Stefano; Olivier Giet; Yves Beguin; André Gothot
Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice.
Haematologica 2009;94(2):185-94.
2009: Emilie Castermans; M Hannon; Pierre Drion; Vincent Geenen; Yves Beguin; Frédéric Baron
[Immune recovery following allogeneic hematopoietic cell transplantation].
Revue médicale de Liège 2009;64 Spec No():2-8.
2009: Gabriel Morrhaye; Hamid Kermani; Jean-Jacques Legros; Frederic Baron; Yves Beguin; Michel Moutschen; remi cheynier; Henri Martens; Vincent Geenen
Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.
PloS one 2009;4(5):e5668.
2009: E Willems; Jean-Luc Canivet; Benoit Ghaye; L de Leval; MF Radermecker; J-C Preiser; Yves Beguin
Pulmonary veno-occlusive disease in myeloproliferative disorder.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2009;33(1):213-6.
2008: Claire Hoyoux; Marie-Françoise Dresse; Sébastien Robinet; Patricia Forget; Catherine Pieltain; Olivier Ketelslegers; Yves Beguin
Cord blood transplantation in a child with Pearson's disease.
Pediatric blood & cancer 2008;51(4):566.
2008: M Lejeune; Yves Beguin; B De Prijck; Marie-France Fassotte; Georges Fillet; Frédéric Baron
[How I treat... Acute myeloid leukemia in older patients with good performance status].
Revue médicale de Liège 2008;63(2):59-63.
2008: Emilie Castermans; Frédéric Baron; Evelyne Willems; Nicole Schaaf-Lafontaine; Nathalie Meuris; André Gothot; Jean-François Vanbellighen; Christian Herens; Laurence Seidel; Vincent Geenen; remi cheynier; Yves Beguin
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Haematologica 2008;93(2):240-7.
2007: Emilie Castermans; G Morrhaye; S Marchand; Henri Martens; Michel Moutschen; Vincent Geenen; Yves Beguin; Frédéric Baron
[Evaluation of thymopoiesis: clinical applications].
Revue médicale de Liège 2007;62(12):725-9.
2007: Emilie Castermans; G Morrhaye; S Marchand; Henri Martens; Michel Moutschen; Frédéric Baron; Yves Beguin; Vincent Geenen
[Clinical evaluation of thymic function].
Revue médicale de Liège 2007;62(11):675-8.
2007: Christophe Bonnet; Yves Beguin; Marie-France Fassotte; Laurence Seidel; Françoise Luyckx; Georges Fillet
Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
European journal of haematology 2007;78(5):399-404.
2007: Christophe Bovy; André Gothot; Pierre Delanaye; Xavier Warling; Jean-Marie Krzesinski; Yves Beguin
Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(4):1156-62.
2006: Frédéric Baron; Gaëtan Vanstraelen; Yves Beguin
Transfusions after nonmyeloablative or reduced-intensity conditioning regimens.
Leukemia 2006;20(12):2081-6.
2006: Christophe Bovy; Etienne Baudoux; Jean Pol Salmon; Yves Beguin
Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
Transfusion 2006;46(9):1616-23.
2006: Nancy Van Overstraeten-Schlögel; Marie Delgaudine; Yves Beguin; André Gothot
Limitations of the use of GFP transgenic mice in bone marrow transplantation studies.
Leukemia & lymphoma 2006;47(7):1392-3.
2006: Gaëtan Vanstraelen; Frédéric Baron; Evelyne Willems; Christophe Bonnet; Kaoutar Hafraoui; Pascale Frère; Georges Fillet; Yves Beguin
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Experimental hematology 2006;34(7):841-50.
2006: Laurence Pirson; Frédéric Baron; Nathalie Meuris; Olivier Giet; Emilie Castermans; Roland Greimers; Ivano Di Stefano; André Gothot; Yves Beguin
Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.
Stem cells (Dayton, Ohio) 2006;24(7):1814-21.
2006: Nancy Van Overstraeten-Schlögel; Yves Beguin; André Gothot
Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
European journal of haematology 2006;76(6):488-93.
2006: Gaëtan Vanstraelen; Pascale Frère; Marie-Christine Ngirabacu; Evelyne Willems; Georges Fillet; Yves Beguin
Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation.
Experimental hematology 2006;34(3):382-8.
2006: Pascale Frère; Frédéric Baron; Christophe Bonnet; Kaoutar Hafraoui; M Pereira; Evelyne Willems; Georges Fillet; Yves Beguin
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen.
Bone marrow transplantation 2006;37(4):411-8.
2006: Pascale Frère; Maguy Pereira; Georges Fillet; Yves Beguin
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
European journal of haematology 2006;76(2):102-8.
2005: Gaëtan Vanstraelen; Frédéric Baron; Pascale Frère; Kaoutar Hafraoui; Georges Fillet; Yves Beguin
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation.
Haematologica 2005;90(9):1269-70.
2005: Guy Jerusalem; Roland Hustinx; Yves Beguin; Georges Fillet
Positron emission tomography imaging for lymphoma.
Current opinion in oncology 2005;17(5):441-5.
2005: Evelyne Willems; Frédéric Baron; Gaëtan Vanstraelen; Pascale Frère; Georges Fillet; Yves Beguin
[Nonmyeloablative stem cell transplantation as cancer immunotherapy].
Revue médicale suisse 2005;1(30):1973-7.
2005: Guy Jerusalem; Roland Hustinx; Yves Beguin; Georges Fillet
Evaluation of therapy for lymphoma.
Seminars in nuclear medicine 2005;35(3):186-96.
2005: Christophe Bovy; André Gothot; Jean-Marie Krzesinski; Yves Beguin
Mature erythrocyte indices: new markers of iron availability.
Haematologica 2005;90(4):549-51.
2005: Jacques Foguenne; Sandra Huygen; Roland Greimers; Yves Beguin; André Gothot
Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion.
Haematologica 2005;90(4):445-51.
2005: Y Bataille; Christophe Bovy; P Lancellotti; V Melchior; K Delbecque; Yves Beguin; J M Krzesinski
Primary amyloidosis (AL) as a cause of nephrotic syndrome.
Acta clinica Belgica 2005;60(2):94-7.
2005: C Piette; Marie-Françoise Dresse; P Forget; Véronique Schmitz; M Demarche; P Erpicum; MT Closon; Isabelle Rutten; P Paulus; D Vivegnis; Yves Beguin; P Jamblin; Cl Hoyoux
[Clinical evaluation of 23 children with neuroblastoma. The experience of a single institution].
Revue médicale de Liège 2005;60(3):173-80.
2004: Frédéric Baron; Sandra Copizza; Etienne Baudoux; Guy Jerusalem; Georges Fillet; Yves Beguin
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer.
Haematologica 2004;89(9):1146-8.
2004: Christophe Bovy; Jean-Marie Krzesinski; André Gothot; Yves Beguin
Impact of erythropoietic activity on red cell parameters in chronic renal failure patients.
Haematologica 2004;89(6):748-9.
2004: Pascale Frère; Jean-Philippe Hermanne; M-H Debouge; Patrick De Mol; Georges Fillet; Yves Beguin
Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures.
Bone marrow transplantation 2004;33(7):745-9.
2003: Frédéric Baron; Nicole Schaaf-Lafontaine; Stéphanie Humblet-Baron; Nathalie Meuris; Emilie Castermans; Etienne Baudoux; Pascale Frère; Vincent Bours; Georges Fillet; Yves Beguin
T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
Transplantation 2003;76(12):1705-13.
2003: Stéphanie Humblet-Baron; Frédéric Baron; Yves Beguin; Alfred Chachati; Jean Bury; Emmanuel Morelon; Henri Kreis
Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Transplantation 2003;76(10):1531-2.
2003: Frédéric Baron; Pascale Frère; Georges Fillet; Yves Beguin
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5566-72.
2003: Frédéric Baron; Etienne Baudoux; Pascale Frère; S Tourqui; Nicole Schaaf-Lafontaine; Christian Herens; B DePrijck; Georges Fillet; Yves Beguin
Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC.
Bone marrow transplantation 2003;32(8):829-34.
2003: Frédéric Baron; Pascale Frère; Georges Fillet; Yves Beguin
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion.
British journal of haematology 2003;123(1):103-5.
2003: Frédéric Baron; Marie-Françoise Dresse; Yves Beguin
Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation.
The New England journal of medicine 2003;349(9):913-4.
2003: André Gothot; Olivier Giet; Sandra Huygen; Yves Beguin
Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells.
Leukemia & lymphoma 2003;44(8):1379-83.
2003: Mario Cazzola; Yves Beguin; Janusz Kloczko; Ivan Spicka; Bertrand Coiffier
Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production.
British journal of haematology 2003;122(3):386-93.
2003: Frédéric Baron; Pascale Frère; Etienne Baudoux; Nicole Schaaf-Lafontaine; Georges Fillet; Yves Beguin
Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update.
Haematologica 2003;88(7):835-7.
2003: Frédéric Baron; Pascale Frère; Yves Beguin
Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment.
Haematologica 2003;88(6):718-20.
2003: Frédéric Baron; Pascale Frère; Etienne Baudoux; Brieuc Sautois; Georges Fillet; Yves Beguin
Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma.
Haematologica 2003;88(4):478-80.
2003: Yves Beguin
Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.
Clinica chimica acta; international journal of clinical chemistry 2003;329(1-2):9-22.
2003: Yves Beguin; Frédéric Baron
Minitransplants: allogeneic stem cell transplantation with reduced toxicity.
Acta clinica Belgica 2003;58(1):37-45.
2003: Kaoutar Hafraoui; Stéphanie Humblet-Baron; Frédéric Baron; Yves Beguin; Georges Fillet
[How I treat...chronic myeloid leukemia].
Revue médicale de Liège 2003;58(1):7-12.
2003: Marc André; Etienne Baudoux; Dominique Bron; Jean-Luc Canon; Véronique D'Hondt; Marie-France Fassotte; Lionel D'Hondt; Georges Fillet; Yves Humblet; Guy Jerusalem; Philippe Vermeulen; Michel Symann; Yves Beguin
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies.
Transfusion 2003;43(1):50-7.
2003: Guy Jerusalem; Yves Beguin; Marie-France Fassotte; Tarik Z Belhocine; Roland Hustinx; Pierre Rigo; Georges Fillet
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):123-30.
2002: Frédéric Baron; Georges Fillet; Yves Beguin
Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.
Transplantation 2002;74(12):1692-6.
2002: V Warland; G Jérusalem; Roland Hustinx; Yves Beguin; RM Silvestre; Marie-France Fassotte; Jacqueline Foidart-Willems; Georges Fillet
[End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma].
Revue médicale de Liège 2002;57(12):779-84.
2002: Frédéric Baron; Pascale Frère; Christian Herens; Georges Fillet; Yves Beguin
Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
Haematologica 2002;87(12):ECR43.
2002: Yves Beguin; Yves Benoit; F Crokaert; Dominik Selleslag; B Vandercam
Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.
Acta clinica Belgica 2002;57(6):309-16.
2002: Sandra Huygen; Olivier Giet; Vincent Artisien; Ivano Di Stefano; Yves Beguin; André Gothot
Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture.
Blood 2002;100(8):2744-52.
2002: Frédéric Baron; Etienne Baudoux; Georges Fillet; Yves Beguin
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
Hematology (Amsterdam, Netherlands) 2002;7(3):137-43.
2002: Frédéric Baron; Brieuc Sautois; Etienne Baudoux; Geoffrey Matus; Georges Fillet; Yves Beguin
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2002;30(6):546-54.
2002: Frédéric Baron; Etienne Baudoux; Pascale Frère; Soraya Tourqui; Nicole Schaaf-Lafontaine; Roland Greimers; Christian Herens; Georges Fillet; Yves Beguin
Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells.
Journal of hematotherapy & stem cell research 2002;11(2):301-14.
2002: Frédéric Baron; Yves Beguin
Nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):243-63.
2002: Pascale Frère; Jean-Philippe Hermanne; M-H Debouge; Georges Fillet; Yves Beguin
Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients.
Bone marrow transplantation 2002;29(7):589-94.
2002: Olivier Giet; Dirk R Van Bockstaele; Ivano Di Stefano; Sandra Huygen; Roland Greimers; Yves Beguin; André Gothot
Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells.
Blood 2002;99(6):2023-31.
2002: Guy Jerusalem; Roland Hustinx; Yves Beguin; Georges Fillet
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():227-34.
2002: Frédéric Baron; Yves Beguin
Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):351-9.
2002: Frédéric Baron; Jean Siquet; Nicole Schaaf-Lafontaine; Etienne Baudoux; Jean-Philippe Hermanne; Georges Fillet; Yves Beguin
Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
Haematologica 2002;87(1):78-88.
2001: Brieuc Sautois; Etienne Baudoux; Jean Pol Salmon; S Michaux; Nicole Schaaf-Lafontaine; M Pereira; Jean-Michel Paulus; Georges Fillet; Yves Beguin
Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
Haematologica 2001;86(11):1209-18.
2001: Guy Jerusalem; Yves Beguin; F Najjar; Roland Hustinx; Marie-France Fassotte; Pierre Rigo; Georges Fillet
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):825-30.
2001: S R'Zik; Yves Beguin
Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors.
Experimental hematology 2001;29(6):677-85.
2001: Olivier Giet; Sandra Huygen; Yves Beguin; André Gothot
Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin.
Experimental hematology 2001;29(4):515-24.
2001: Guy Jerusalem; Yves Beguin; Marie-France Fassotte; F Najjar; P Paulus; Pierre Rigo; Georges Fillet
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
Haematologica 2001;86(3):266-73.
2001: S R'Zik; M Loo; Yves Beguin
Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels.
Haematologica 2001;86(3):244-51.
2001: M Piron; M Loo; André Gothot; Francoise Tassin; Georges Fillet; Yves Beguin
Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.
Blood 2001;97(2):442-8.
2000: Frédéric Baron; André Gothot; Jean Pol Salmon; Jean-Philippe Hermanne; Gerald E Pierard; Georges Fillet; Yves Beguin
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
British journal of haematology 2000;111(3):745-53.
2000: Frédéric Baron; Marie-Françoise Dresse; Yves Beguin
Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease.
Transfusion 2000;40(9):1071-3.
2000: Frédéric Baron; Clio Ribbens; Olivier Kaye; Georges Fillet; Michel Malaise; Yves Beguin
Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation.
British journal of haematology 2000;110(2):339-42.
2000: P Frere; Jean-Luc Canivet; C Gennigens; J P Rebeix; Georges Fillet; Yves Beguin
Hyperammonemia after high-dose chemotherapy and stem cell transplantation.
Bone marrow transplantation 2000;26(3):343-5.
2000: Christian Herens; Francoise Tassin; Vincent Lemaire; Yves Beguin; E Collard; Serge Lampertz; Christiane Croisiau; M Lecomte; B De Prijk; L Longrée; L Koulischer
Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients.
British journal of haematology 2000;110(1):214-6.
2000: Guy Jerusalem; Yves Beguin; Marie-France Fassotte; F Najjar; P Paulus; Pierre Rigo; Georges Fillet
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma.
Haematologica 2000;85(6):613-8.
2000: Frédéric Baron; Yves Beguin
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation.
Transfusion 2000;40(4):468-76.
2000: Clio Ribbens; Valérie Bonnet; Marie-Joëlle Kaiser; B Andre; Olivier Kaye; Nathalie Franchimont; DD De Groote; Yves Beguin; Michel Malaise
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA).
Clinical and experimental immunology 2000;120(1):194-9.
2000: Vincent Fraipont; Brieuc Sautois; Etienne Baudoux; M Pereira; Marie-France Fassotte; Jean-Philippe Hermanne; G Jérusalem; L Longrée; Nicole Schaaf-Lafontaine; Georges Fillet; Yves Beguin
Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF.
Transfusion 2000;40(3):339-47.
2000: Francoise Tassin; Walthère Dewé; N Schaaf; Christian Herens; C Ravoet; Adelin Albert; Yves Beguin; Jean-Michel Paulus
A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes.
Leukemia & lymphoma 2000;36(5-6):485-96.
1999: Mario Cazzola; Yves Beguin; Gaetano Bergamaschi; R Guarnone; Paola Cerani; Susanna Barella; Antonio Cao; Renzo Galanello
Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis.
British journal of haematology 1999;106(3):752-5.
1999: Jean Pol Salmon; S Michaux; Jean-Philippe Hermanne; Etienne Baudoux; Christiane Gérard; D Sontag-Thull; Georges Fillet; Yves Beguin
Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation.
Transfusion 1999;39(8):824-7.
1999: Guy Jerusalem; Yves Beguin; Marie-France Fassotte; F Najjar; P Paulus; Pierre Rigo; Georges Fillet
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
Blood 1999;94(2):429-33.
1999: Marie-Françoise Dresse; Marc Boogaerts; Christiane Vermylen; Lucien Noens; Augustin Ferrant; R Schots; Chantal Doyen; D Bron; Zwi Berneman; Alina Ferster; Yves Benoit; Hilde Demuynck; Yves Beguin
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor.
Haematologica 1999;84(7):637-42.
1999: Yves Beguin
Erythropoietin and platelet production.
Haematologica 1999;84(6):541-7.
1999: M Loo; Yves Beguin
The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply.
Blood 1999;93(10):3286-93.
1999: Brieuc Sautois; Vincent Fraipont; Etienne Baudoux; Marie-France Fassotte; Jean-Philippe Hermanne; G Jérusalem; Vincent Bours; L Bosquée; Nicole Schaaf-Lafontaine; Jean-Michel Paulus; D Sondag; Georges Fillet; Yves Beguin
Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
Haematologica 1999;84(4):342-9.
1999: Guy Cornu; Christiane Vermylen; Alina Ferster; Bénédicte Brichard; J Ninane; A Ferrant; A Zenebergh; Philip Maes; Catharina Dhooge; Yves Benoit; Yves Beguin; Marie-Françoise Dresse; Eric Sariban
[Hematopoietic stem cell transplantation in sickle cell anemia].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 1999;6 Suppl 2():345s-347s.
1998: Yves Beguin; Frédéric Baron; Georges Fillet
Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation.
Haematologica 1998;83(12):1076-81.
1998: Frédéric Baron; Jean-Philippe Hermanne; Marie-France Fassotte; Yves Beguin; Georges Fillet
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
Revue médicale de Liège 1998;53(11):651-3.
1998: Yves Beguin
A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.
Drug safety : an international journal of medical toxicology and drug experience 1998;19(4):269-82.
1998: Yves Beguin
Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
Medical oncology (Northwood, London, England) 1998;15 Suppl 1():S38-46.
1998: Etienne Baudoux; Yves Beguin; Guy Cornu; Bénédicte Brichard; C Debruyn; M De Bruyère; D De Hemptinne; Alain Delforge; Véronique Deneys; Georges Fillet; N Germeau; I Joris; P Lefèvre; Martine Massy; Jean-Michel Paulus; N Raymakers; Jean-Pierre Schaaps; D Sondag; JR Van Cauwenberge; Christiane Vermylen; P Strijckmans
Circadian and seasonal variations of hematopoiesis in cord blood.
Bone marrow transplantation 1998;22 Suppl 1():S12.
1998: Frédéric Baron; Bernard Sadzot; F Wang; Yves Beguin
Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(2):197-200.
1998: Christiane Vermylen; Guy Cornu; Alina Ferster; Bénédicte Brichard; J Ninane; Augustin Ferrant; A Zenebergh; Philip Maes; Catharina Dhooge; Yves Benoit; Yves Beguin; Marie-Françoise Dresse; Eric Sariban
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.
Bone marrow transplantation 1998;22(1):1-6.
1998: Frédéric Baron; Jean-Philippe Hermanne; Afshin Dowlati; T Weber; Albert Thiry; Marie-France Fassotte; Georges Fillet; Yves Beguin
Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;21(9):951-4.
1998: Mario Cazzola; R Guarnone; Paola Cerani; E Centenara; A Rovati; Yves Beguin
Red blood cell precursor mass as an independent determinant of serum erythropoietin level.
Blood 1998;91(6):2139-45.
1998: Yves Beguin; Etienne Baudoux; Brieuc Sautois; Vincent Fraipont; Nicole Schaaf-Lafontaine; M Pereira; Jean-Michel Paulus; D Sondag; Georges Fillet
Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells.
Transfusion 1998;38(2):199-208.
1997: Frédéric Baron; Manuel Deprez; Yves Beguin
The veno-occlusive disease of the liver.
Haematologica 1997;82(6):718-25.
1997: Yves Beguin; V Grek; G Weber; Brieuc Sautois; Nicolas Paquot; M Pereira; A Scheen; P Lefèbvre; Georges Fillet
Acute functional iron deficiency in obese subjects during a very-low-energy all-protein diet.
The American journal of clinical nutrition 1997;66(1):75-9.
1997: Afshin Dowlati; S R'Zik; Georges Fillet; Yves Beguin
Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production.
British journal of haematology 1997;97(2):297-9.
1997: Yves Beguin; Brieuc Sautois; P Forget; J Bury; Georges Fillet
Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen.
Cancer 1997;79(7):1351-4.
1997: Frédéric Baron; Yves Beguin
[Hepatic complications of chemotherapy. From trivial cytolysis to hepatic veno-occlusive disease].
Revue médicale de Liège 1997;52(2):93-7.
1997: Mario Cazzola; Caterina Borgna-Pignatti; Franco Locatelli; Luisa Ponchio; Yves Beguin; Piero De Stefano
A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
Transfusion 1997;37(2):135-40.
1997: Brieuc Sautois; Georges Fillet; Yves Beguin
Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood.
Experimental hematology 1997;25(2):103-8.
1997: Afshin Dowlati; M Loo; Th Bury; Georges Fillet; Yves Beguin
Soluble and cell-associated transferrin receptor in lung cancer.
British journal of cancer 1997;75(12):1802-6.
1996: V Pasquasy; Philippe Delvenne; Albert Thiry; Yves Beguin; Jacques Boniver
[Thrombotic thrombocytopenic purpura in bone marrow graft rejection (clin conference)].
Revue médicale de Liège 1996;51(11):714-7.
1996: Mario Cazzola; Luisa Ponchio; C Pedrotti; G Farina; Paola Cerani; C Lucotti; A Novella; A Rovati; Gaetano Bergamaschi; Yves Beguin
Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.
Haematologica 1996;81(5):434-41.
1996: Yves Beguin; J Collignon; C Laurent; Georges Fillet
Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome.
British journal of haematology 1996;94(3):507-9.
1996: Mario Cazzola; Luisa Ponchio; de benedetti fabrizio; Angelo Ravelli; Vittorio Rosti; Yves Beguin; Rosangela Invernizzi; Giovanni Barosi; Alberto Martini
Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Blood 1996;87(11):4824-30.
1996: Yves Beguin
[Hematopoietic stem cell transplantation ("Bone marrow graft"): indications, methods and risks].
Revue médicale de Liège 1996;51(4):270-5.
1996: Yves Beguin; S Lampertz; D Bron; Georges Fillet
Serum erythropoietin in chronic lymphocytic leukaemia.
British journal of haematology 1996;93(1):154-6.
1995: Yves Beguin
[Pharma-clinics. How I treat... anemia (3)].
Revue médicale de Liège 1995;50(12):497-8.
1995: Yves Beguin
[How I examine... anemia (2)].
Revue médicale de Liège 1995;50(11):487-8.
1995: Yves Beguin
[How I examine... Anemia (1)].
Revue médicale de Liège 1995;50(10):443-4.
1995: Yves Beguin
Erythropoiesis and erythropoietin in multiple myeloma.
Leukemia & lymphoma 1995;18(5-6):413-21.
1995: Afshin Dowlati; P Honore; Pierre Damas; Manuel Deprez; Jean Delwaide; Georges Fillet; Yves Beguin
Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
Transplantation 1995;60(1):106-9.
1995: Mario Cazzola; Piero De Stefano; Luisa Ponchio; Franco Locatelli; Yves Beguin; C Dessi; Susanna Barella; Antonio Cao; Renzo Galanello
Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major.
British journal of haematology 1995;89(3):473-8.
1995: Yves Beguin; M Loo; S R'Zik; Brieuc Sautois; F Lejeune; G Rorive; Georges Fillet
Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin.
British journal of haematology 1995;89(1):17-23.
1994: Franco Locatelli; Marco Zecca; Luisa Ponchio; Yves Beguin; Giovanna Giorgiani; Rita Maccario; Federico Bonetti; Piero De Stefano; Mario Cazzola
Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14(6):929-35.
1994: Yves Beguin; M Loo; S R'Zik; Brieuc Sautois; F Lejeune; G Rorive; Georges Fillet
Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters.
European journal of haematology 1994;53(5):265-70.
1994: Vincent Fraipont; Yves Beguin; Georges Fillet
[Iron-deficiency anemia in pregnancy].
Revue médicale de Liège 1994;49(8):436-45.
1994: Franco Locatelli; Marco Zecca; Paolo Pedrazzoli; L Prete; Silvana Quaglini; Patrizia Comoli; Piero De Stefano; Yves Beguin; Gioacchino Robustelli Della Cuna; Francesca Severi
Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
Bone marrow transplantation 1994;13(4):403-10.
1993: Yves Beguin; S Lampertz; D De Groote; D Igot; M Malaise; Georges Fillet
Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Leukemia 1993;7(12):2019-25.
1993: Yves Beguin; M Loo; S R'Zik; Brieuc Sautois; F Lejeune; G Rorive; Georges Fillet
Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.
Blood 1993;82(7):2010-6.
1993: Franco Locatelli; Marco Zecca; Yves Beguin; Giovanna Giorgiani; Luisa Ponchio; Piero De Stefano; Mario Cazzola
Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
British journal of haematology 1993;84(4):752-4.
1993: Yves Beguin; R Oris; Georges Fillet
Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
Bone marrow transplantation 1993;11(4):285-92.
1993: Yves Beguin; G K Clemons; P Pootrakul; Georges Fillet
Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
Blood 1993;81(4):1067-76.
1993: Yves Beguin
[Quantitative measures of erythropoiesis. Soluble transferrin receptor].
Bulletin et mémoires de l'Académie royale de médecine de Belgique 1993;148(1-2):100-4; discussion 105-7.
1993: C Feron; A Gothot; J C Grosdent; JR Van Cauwenberge; Jean-Pierre Schaaps; Yves Beguin; Jean-Michel Paulus
Purification, expansion, and multiple fluorochrome labeling of cord blood hemopoietic precursors: preliminary results.
Journal of hematotherapy 1993;2(2):259-61.
1992: Yves Beguin; M Yerna; M Loo; M Weber; Georges Fillet
Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production.
British journal of haematology 1992;82(4):648-53.
1992: Luisa Ponchio; Yves Beguin; G Farina; Paolo Pedrazzoli; C Pedrotti; Geraldina Poggi; Vittorio Rosti; Gaetano Bergamaschi; V Battistel; Mario Cazzola
Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Haematologica 1992;77(6):494-501.
1992: DD De Groote; P F Zangerle; Y Gevaert; Marie-France Fassotte; Yves Beguin; F Noizat-Pirenne; J Pirenne; R Gathy; M Lopez; I Dehart
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation.
Cytokine 1992;4(3):239-48.
1992: Mario Cazzola; Yves Beguin
New tools for clinical evaluation of erythron function in man.
British journal of haematology 1992;80(3):278-84.
1992: N Antoine; C Beckers; C Marcoty; A Bosseloir; Yves Beguin; Nicole Schaaf-Lafontaine; L J Simar
[Expression of DRC1 antigen by leukemic cells].
Revue médicale de Liège 1992;47(2):95-9.
1992: Mario Cazzola; Luisa Ponchio; Yves Beguin; Vittorio Rosti; Gaetano Bergamaschi; Nicola Liberato; V Fregoni; G Nalli; Giovanni Barosi; Edoardo Ascari
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.
Blood 1992;79(1):29-37.
1992: A Elira-Dokekias; S R'Zik; Yves Beguin; Georges Fillet
Monitoring of erythropoiesis by serum transferrin receptor levels in a case of chronic lymphocytic leukaemia and pure red cell aplasia treated with ciclosporin.
Nouvelle revue française d'hématologie 1992;34(3):257-8.
1991: Yves Beguin; G Lipscei; HJ Thoumsin; Georges Fillet
Blunted erythropoietin production and decreased erythropoiesis in early pregnancy.
Blood 1991;78(1):89-93.
1991: Yves Beguin; G K Clemons; R Oris; Georges Fillet
Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.
Blood 1991;77(4):868-73.
1990: Yves Beguin; G Lipscei; R Oris; HJ Thoumsin; Georges Fillet
Serum immunoreactive erythropoietin during pregnancy and in the early postpartum.
British journal of haematology 1990;76(4):545-9.
1990: Yves Beguin; Marie-France Fassotte; F Hay; A Dokekias; F Andrien; Vincent Bours; Michel Moutschen; V Runde; J Bury; Georges Fillet
[Bone marrow grafts: current status at the University Hospital Center in Liège].
Revue médicale de Liège 1990;45(6):268-79.
1990: Yves Beguin; Georges Fillet
[Erythropoietin: diagnostic and therapeutic use].
Revue médicale de Liège 1990;45(6):261-7.
1989: Yves Beguin; Vincent Bours; J M Delbrouck; G Robaye; I Roelandts; J Bury; Georges Fillet; G Weber
Relationship of serum selenium levels to tumor activity in acute non-lymphocytic leukemia.
Carcinogenesis 1989;10(11):2089-91.
1989: Yves Beguin; Georges Fillet; J Bury; Y Fairon
Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis.
American journal of hematology 1989;32(2):123-8.
1989: Georges Fillet; Yves Beguin; L Baldelli
Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation.
Blood 1989;74(2):844-51.
1989: V Grek; F Hay; Yves Beguin; F Andrien; A Dokekias; Georges Fillet
[Hairy cell leukemia: 30 years later].
Revue médicale de Liège 1989;44(10):358-64.
1989: Jean-Olivier Defraigne; M T Closon; L Bruyninx; J M Dewandre; P Hourlay; Michel Meurisse; P Honore; J Bury; Yves Beguin
Experience with a totally implantable catheter in adult patients: a single institution retrospective study of 114 cases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1989;15(1):61-4.
1987: Yves Beguin; F Brasseur; G Weber; J Bury; J M Delbrouck; I Roelandts; G Robaye; Georges Fillet
Observations of serum trace elements in chronic lymphocytic leukemia.
Cancer 1987;60(8):1842-6.
1987: J Bury; F Andrien; M Baudrihaye; Yves Beguin; A Duvivier; C Hoyoux; V Runde; Georges Fillet
[Marrow transplantation: preliminary results at the University Hospital Center].
Revue médicale de Liège 1987;42(10):510-5.
1987: Georges Fillet; J Bury; Yves Beguin; A Duvivier; C Hoyoux; Vincent Bours
[Hematologic cancers in 1987. Chemotherapy and immunotherapy].
Revue médicale de Liège 1987;42(10):496-502.
1987: Yves Beguin; J Bury; J M Delbrouck; Georges Fillet; G Robaye; I Roelandts; G Weber
Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia.
Haematology and blood transfusion 1987;30():380-4.
1986: Yves Beguin; G Weber; J M Delbrouck; I Roelandts; G Robaye; J Bury; Georges Fillet
Serum trace elements during chemotherapy for acute myelogenous leukemia.
Acta pharmacologica et toxicologica 1986;59 Suppl 7():270-3.